EDGAR Filing Documents for 0001493152-15-001853

Form 8-K - Current report:

SEC Accession No. 0001493152-15-001853

Filing Date

2015-05-12

Accepted

2015-05-12 07:30:58

Documents

Period of Report

2015-05-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	40303
2		ex10-1.htm	EX-10.1	479643
3		ex10-2.htm	EX-10.2	81702
4		ex99-1.htm	EX-99.1	14622
5		image1.jpg	GRAPHIC	7548
	Complete submission text file	0001493152-15-001853.txt		628320

Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130

Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042

Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)